Positive Angle Kappa

Sponsor

University of Minnesota (Other)

Overall Status

Completed

CT.gov ID

NCT01644552

Collaborator

(none)

Enrollment

Location

Duration (Months)

1.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Patients with aniridia have positive angle kappas.

Condition or Disease	Intervention/Treatment	Phase
Aniridia

Study Design

Study Type:

Observational

Actual Enrollment :

16 participants

Observational Model:

Case-Only

Time Perspective:

Retrospective

Official Title:

Positive Angle Kappa: a Sign in Aniridia

Study Start Date :

Aug 1, 2010

Actual Primary Completion Date :

Sep 1, 2011

Actual Study Completion Date :

Sep 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
eye examinations

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

1 Month to 85 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

patients with aniridia only

Exclusion Criteria:

poor va
PK,
K-pro

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Minnesota Dept of ophthalmlogy	Minneapolis	Minnesota	United States	55455

Sponsors and Collaborators

University of Minnesota

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

University of Minnesota

ClinicalTrials.gov Identifier:

NCT01644552

Other Study ID Numbers:

1004M80112

First Posted:

Jul 19, 2012

Last Update Posted:

Nov 1, 2019

Last Verified:

Oct 1, 2019

Keywords provided by University of Minnesota

aniridia

positive angle kappa

Additional relevant MeSH terms:

Aniridia

Study Results

No Results Posted as of Nov 1, 2019